GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The FDA and EMA's joint guidance was created to ensure the pharmaceutical industry employs best practices when using AI in ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...
The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...
Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...
The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback